EDWARDS LIFESCIENCES LIMITED

Edwards Lifesciences is a global medical-technology company dedicated to improving the lives of people living with cardiovascular disease. Driven by a patient-focused passion, the firm develops and supplies innovative solutions that help clinicians treat complex heart conditions with less invasive approaches.

The company's core portfolio centres on transcatheter heart-valve technologies, including specialised devices for aortic, mitral and tricuspid valve disease, as well as surgical valve technologies and implantable systems for heart-failure management. In addition, Edwards Lifesciences Critical Care, now part of Becton, Dickinson and Company, expands its reach into critical-care monitoring and support. Through ongoing clinical research, Edwards creates new hope for patients, care partners and healthcare professionals, while its corporate impact programme underpins responsible citizenship and global charitable giving.

By combining cutting-edge engineering with human inspiration, Edwards Lifesciences continues to deliver life-changing therapies that enable patients to take control of conditions such as severe aortic stenosis and to look forward to a healthier future.